Cargando…

Epidemiology of Mucormycosis in India

Mucormycosis is an angioinvasive disease caused by saprophytic fungi of the order Mucorales. The exact incidence of mucormycosis in India is unknown due to the lack of population-based studies. The estimated prevalence of mucormycosis is around 70 times higher in India than that in global data. Diab...

Descripción completa

Detalles Bibliográficos
Autores principales: Prakash, Hariprasath, Chakrabarti, Arunaloke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8000977/
https://www.ncbi.nlm.nih.gov/pubmed/33806386
http://dx.doi.org/10.3390/microorganisms9030523
_version_ 1783671122174148608
author Prakash, Hariprasath
Chakrabarti, Arunaloke
author_facet Prakash, Hariprasath
Chakrabarti, Arunaloke
author_sort Prakash, Hariprasath
collection PubMed
description Mucormycosis is an angioinvasive disease caused by saprophytic fungi of the order Mucorales. The exact incidence of mucormycosis in India is unknown due to the lack of population-based studies. The estimated prevalence of mucormycosis is around 70 times higher in India than that in global data. Diabetes mellitus is the most common risk factor, followed by haematological malignancy and solid-organ transplant. Patients with postpulmonary tuberculosis and chronic kidney disease are at additional risk of developing mucormycosis in this country. Trauma is a risk factor for cutaneous mucormycosis. Isolated renal mucormycosis in an immunocompetent host is a unique entity in India. Though Rhizopus arrhizus is the most common etiological agent of mucormycosis in this country, infections due to Rhizopus microsporus, Rhizopus homothallicus, and Apophysomyces variabilis are rising. Occasionally, Saksenaea erythrospora, Mucor irregularis, and Thamnostylum lucknowense are isolated. Though awareness of the disease has increased among treating physicians, disease-associated morbidity and mortality are still high, as patients seek medical attention late in the disease process and given the low affordability for therapy. In conclusion, the rise in the number of cases, the emergence of new risk factors and causative agents, and the challenges in managing the disease are important concerns with mucormycosis in India.
format Online
Article
Text
id pubmed-8000977
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-80009772021-03-28 Epidemiology of Mucormycosis in India Prakash, Hariprasath Chakrabarti, Arunaloke Microorganisms Review Mucormycosis is an angioinvasive disease caused by saprophytic fungi of the order Mucorales. The exact incidence of mucormycosis in India is unknown due to the lack of population-based studies. The estimated prevalence of mucormycosis is around 70 times higher in India than that in global data. Diabetes mellitus is the most common risk factor, followed by haematological malignancy and solid-organ transplant. Patients with postpulmonary tuberculosis and chronic kidney disease are at additional risk of developing mucormycosis in this country. Trauma is a risk factor for cutaneous mucormycosis. Isolated renal mucormycosis in an immunocompetent host is a unique entity in India. Though Rhizopus arrhizus is the most common etiological agent of mucormycosis in this country, infections due to Rhizopus microsporus, Rhizopus homothallicus, and Apophysomyces variabilis are rising. Occasionally, Saksenaea erythrospora, Mucor irregularis, and Thamnostylum lucknowense are isolated. Though awareness of the disease has increased among treating physicians, disease-associated morbidity and mortality are still high, as patients seek medical attention late in the disease process and given the low affordability for therapy. In conclusion, the rise in the number of cases, the emergence of new risk factors and causative agents, and the challenges in managing the disease are important concerns with mucormycosis in India. MDPI 2021-03-04 /pmc/articles/PMC8000977/ /pubmed/33806386 http://dx.doi.org/10.3390/microorganisms9030523 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ).
spellingShingle Review
Prakash, Hariprasath
Chakrabarti, Arunaloke
Epidemiology of Mucormycosis in India
title Epidemiology of Mucormycosis in India
title_full Epidemiology of Mucormycosis in India
title_fullStr Epidemiology of Mucormycosis in India
title_full_unstemmed Epidemiology of Mucormycosis in India
title_short Epidemiology of Mucormycosis in India
title_sort epidemiology of mucormycosis in india
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8000977/
https://www.ncbi.nlm.nih.gov/pubmed/33806386
http://dx.doi.org/10.3390/microorganisms9030523
work_keys_str_mv AT prakashhariprasath epidemiologyofmucormycosisinindia
AT chakrabartiarunaloke epidemiologyofmucormycosisinindia